Back to search
FDAFDA · Food and drugs·Recall number D-0077-2023

Desmopressin Acetate Tablet, 0.2 mg, 100-count box, Rx only, Source NDC: 23155-0490-01; MFG: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816; Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC #: 70518-3493-00.

Published December 14, 2022 · Recall initiated: December 5, 2022

Summary

FDA records drug Class II recall D-0077-2023, published December 14, 2022 and initiated December 5, 2022. Recalling firm: RemedyRepack Inc.; Status: Terminated; Reported quantity: 9 boxes; Lot: Lot # B1817019-082222, Exp. 02/24/2023; B1819127-082322, Exp. 02/26/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug: repackaged product was recalled by the manufacturer for subpotency.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
RemedyRepack Inc.
Distributor
Product was distributed to two different customers in MI.
Lot
Lot # B1817019-082222, Exp. 02/24/2023; B1819127-082322, Exp. 02/26/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Desmopressin Acetate Tablet, 0.2 mg, 100-count box, Rx only, Source NDC: 23155-0490-01; MFG: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816; Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC #: 70518-3493-00. recalled?

Yes. FDA published recall D-0077-2023 on December 14, 2022. Reported hazard: Subpotent Drug: repackaged product was recalled by the manufacturer for subpotency.

What should I do if I have this product?

Voluntary: Firm initiated · Letter